Baxter Operating Income 2010-2025 | BAX
Baxter annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Baxter operating income for the quarter ending June 30, 2025 was $191M, a 199.48% decline year-over-year.
- Baxter operating income for the twelve months ending June 30, 2025 was $340M, a 34.36% decline year-over-year.
- Baxter annual operating income for 2024 was $0.014B, a 98.02% decline from 2023.
- Baxter annual operating income for 2023 was $0.707B, a 124.85% decline from 2022.
- Baxter annual operating income for 2022 was $-2.845B, a 310.74% decline from 2021.
| Baxter Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $14 |
| 2023 | $707 |
| 2022 | $-2,845 |
| 2021 | $1,350 |
| 2020 | $1,616 |
| 2019 | $1,772 |
| 2018 | $1,584 |
| 2017 | $1,288 |
| 2016 | $745 |
| 2015 | $449 |
| 2014 | $656 |
| 2013 | $496 |
| 2012 | $2,770 |
| 2011 | $2,946 |
| 2010 | $2,136 |
| 2009 | $2,877 |
| Baxter Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $191 |
| 2025-03-31 | $58 |
| 2024-12-31 | $-64 |
| 2024-09-30 | $155 |
| 2024-06-30 | $-192 |
| 2024-03-31 | $115 |
| 2023-12-31 | $416 |
| 2023-09-30 | $179 |
| 2023-06-30 | $-17 |
| 2023-03-31 | $129 |
| 2022-12-31 | $-392 |
| 2022-09-30 | $-2,880 |
| 2022-06-30 | $264 |
| 2022-03-31 | $163 |
| 2021-12-31 | $23 |
| 2021-09-30 | $513 |
| 2021-06-30 | $424 |
| 2021-03-31 | $390 |
| 2020-12-31 | $406 |
| 2020-09-30 | $470 |
| 2020-06-30 | $331 |
| 2020-03-31 | $409 |
| 2019-12-31 | $536 |
| 2019-09-30 | $503 |
| 2019-06-30 | $350 |
| 2019-03-31 | $383 |
| 2018-12-31 | $386 |
| 2018-09-30 | $382 |
| 2018-06-30 | $384 |
| 2018-03-31 | $432 |
| 2017-12-31 | $288 |
| 2017-09-30 | $300 |
| 2017-06-30 | $347 |
| 2017-03-31 | $353 |
| 2016-12-31 | $303 |
| 2016-09-30 | $186 |
| 2016-06-30 | $68 |
| 2016-03-31 | $188 |
| 2015-12-31 | $178 |
| 2015-09-30 | $92 |
| 2015-06-30 | $87 |
| 2015-03-31 | $92 |
| 2014-12-31 | $191 |
| 2014-09-30 | $217 |
| 2014-06-30 | $659 |
| 2014-03-31 | $672 |
| 2013-12-31 | $546 |
| 2013-09-30 | $654 |
| 2013-06-30 | $828 |
| 2013-03-31 | $715 |
| 2012-12-31 | $523 |
| 2012-09-30 | $777 |
| 2012-06-30 | $777 |
| 2012-03-31 | $693 |
| 2011-12-31 | $625 |
| 2011-09-30 | $745 |
| 2011-06-30 | $831 |
| 2011-03-31 | $745 |
| 2010-12-31 | $523 |
| 2010-09-30 | $782 |
| 2010-06-30 | $698 |
| 2010-03-31 | $133 |
| 2009-12-31 | $733 |
| 2009-09-30 | $732 |
| 2009-06-30 | $747 |
| 2009-03-31 | $665 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $12.168B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.709B | 27.40 |
| Boston Scientific (BSX) | United States | $152.828B | 36.44 |
| Stryker (SYK) | United States | $144.352B | 29.38 |
| EssilorLuxottica (ESLOY) | France | $136.813B | 0.00 |
| Medtronic (MDT) | Ireland | $119.054B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.435B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.853B | 24.46 |
| ResMed (RMD) | United States | $41.628B | 29.73 |
| GE HealthCare Technologies (GEHC) | United States | $32.872B | 15.45 |
| Agilent Technologies (A) | United States | $32.560B | 21.23 |
| Terumo (TRUMY) | Japan | $27.538B | 32.63 |
| Koninklijke Philips (PHG) | Netherlands | $25.845B | 17.10 |
| Insulet (PODD) | United States | $21.612B | 72.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.663B | 12.52 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.829B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.599B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.150B | 26.26 |
| Lantheus Holdings (LNTH) | United States | $3.889B | 10.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.364B | 23.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.227B | 14.32 |
| Perrigo (PRGO) | Ireland | $3.102B | 7.75 |
| ICU Medical (ICUI) | United States | $2.786B | 18.97 |
| Haemonetics (HAE) | United States | $2.601B | 11.61 |
| LeMaitre Vascular (LMAT) | United States | $2.089B | 44.80 |
| QuidelOrtho (QDEL) | United States | $1.624B | 10.22 |
| Green Thumb Industries (GTBIF) | United States | $1.509B | 64.82 |
| Curaleaf Holdings (CURLF) | Canada | $1.368B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.240B | 17.67 |
| Phibro Animal Health (PAHC) | United States | $1.139B | 14.56 |
| Acuren (TIC) | United States | $1.138B | 0.00 |
| Neogen (NEOG) | United States | $1.103B | 17.52 |
| BioLife Solutions (BLFS) | United States | $1.086B | 2268.00 |
| InMode (INMD) | Israel | $0.892B | 8.25 |
| Valneva SE (VALN) | France | $0.775B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.746B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.714B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.560B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| ZimVie (ZIMV) | United States | $0.530B | 20.45 |
| Surmodics (SRDX) | United States | $0.506B | 0.00 |
| CeriBell (CBLL) | United States | $0.473B | 0.00 |
| SNDL (SNDL) | Canada | $0.441B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.414B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.393B | 13.54 |
| Evolus (EOLS) | United States | $0.382B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.347B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.341B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 20.88 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.251B | 0.00 |
| Cerus (CERS) | United States | $0.232B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.80 |
| Quanterix (QTRX) | United States | $0.221B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.220B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.214B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.203B | 0.00 |
| Exagen (XGN) | United States | $0.202B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.06 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.170B | 0.00 |
| Biote (BTMD) | United States | $0.158B | 4.72 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Safety Shot (SHOT) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.055B | 0.00 |
| Zynex (ZYXI) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 32.50 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.11 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.017B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |